1. Home
  2. PLSE vs VCEL Comparison

PLSE vs VCEL Comparison

Compare PLSE & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$24.74

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.28

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
VCEL
Founded
2014
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
PLSE
VCEL
Price
$24.74
$34.28
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$22.00
$57.75
AVG Volume (30 Days)
347.1K
588.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
N/A
$276,259,000.00
Revenue This Year
$840.00
$19.40
Revenue Next Year
$287.54
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.45
52 Week Low
$12.56
$28.95
52 Week High
$27.98
$45.97

Technical Indicators

Market Signals
Indicator
PLSE
VCEL
Relative Strength Index (RSI) 56.18 49.86
Support Level $17.58 $33.79
Resistance Level $27.14 $34.77
Average True Range (ATR) 1.82 1.49
MACD 0.15 0.01
Stochastic Oscillator 67.22 57.57

Price Performance

Historical Comparison
PLSE
VCEL

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: